Trial Profile

Clinical Study to Investigate the Efficacy and Safety of Wilate During Prophylaxis in Previously Treated Patients With Von Willebrand Disease (VWD)

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 13 Jun 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Factor VIII/von Willebrand factor (Primary)
Indications Von Willebrand disease
Focus Registrational; Therapeutic Use
Sponsors Octapharma

Most Recent Events

10 Jun 2024 According to an Octapharma media release, data from the study will be presented at the upcoming ISTH 2024 Congress
22 Jan 2024 According to an Octapharma media release, results from this study published in the leading medical journal Blood Advances.
22 Jan 2024 Results presented in an Octapharma media release.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com